An International Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children.
Members of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of
rhGH.
A Scientific Statement from the American Heart Association on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents.
The birth of an intersex child prompts a long-term management strategy that involves myriad professionals working with the family. There has been progress in diagnosis, surgical…
This review summarizes efficacy and safety of continuous subcutaneous insulin infusion in children ≤6 years of age, present potential pros and cons of using insulin pumps…
There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral edema and the appropriate site(s) for children with DKA…
